Conquering Diseases

Study Of An Investigational Drug For Lymphoma

Description

Seeking men and women whose chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or non-Hodgkin's lymphoma can no longer be managed with the standard treatment for a study of the safety and effectiveness of an investigational drug.

Overview

We are studying what dose of an investigational drug for chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or non-Hodgkin's lymphoma can be given to people without causing unacceptable side effects. The first group of participants in this study will receive a low dose of the the investigational drug and the next groups will get increasingly higher doses.

What we're hoping for

We hope to learn the best dose of the investigational drug to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or non-Hodgkin's lymphoma.

Additional Information

ClinicalTrials.gov Identifier: NCT03893682

 Principal Investigator

Jan  Cerny, MD, PhD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989